Rank | Gene Set | Z-score |
---|---|---|
1 | * tricarboxylic acid cycle (GO:0006099) | 7.37853147 |
2 | NADH metabolic process (GO:0006734) | 6.99799988 |
3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.54282551 |
4 | oxidative phosphorylation (GO:0006119) | 6.51615141 |
5 | ATP synthesis coupled proton transport (GO:0015986) | 5.87663405 |
6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.87663405 |
7 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.86547698 |
8 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.46272351 |
9 | respiratory electron transport chain (GO:0022904) | 5.33352298 |
10 | electron transport chain (GO:0022900) | 5.20567587 |
11 | regulation of cofactor metabolic process (GO:0051193) | 5.19999361 |
12 | regulation of coenzyme metabolic process (GO:0051196) | 5.19999361 |
13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.17755187 |
14 | oxaloacetate metabolic process (GO:0006107) | 4.94714175 |
15 | protein maturation by protein folding (GO:0022417) | 4.86113751 |
16 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.79228451 |
17 | succinate metabolic process (GO:0006105) | 4.79109627 |
18 | quinone biosynthetic process (GO:1901663) | 4.68168422 |
19 | ubiquinone biosynthetic process (GO:0006744) | 4.68168422 |
20 | sarcomere organization (GO:0045214) | 4.52307299 |
21 | aerobic respiration (GO:0009060) | 4.36034840 |
22 | ribosomal small subunit assembly (GO:0000028) | 4.21548412 |
23 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.19203358 |
24 | GDP-mannose metabolic process (GO:0019673) | 4.15211913 |
25 | regulation of sulfur metabolic process (GO:0042762) | 4.09103310 |
26 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.02276021 |
27 | NADH dehydrogenase complex assembly (GO:0010257) | 4.02276021 |
28 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.02276021 |
29 | DNA deamination (GO:0045006) | 3.98500491 |
30 | ubiquinone metabolic process (GO:0006743) | 3.96371331 |
31 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.94249614 |
32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.93489264 |
33 | actin-myosin filament sliding (GO:0033275) | 3.91357389 |
34 | muscle filament sliding (GO:0030049) | 3.91357389 |
35 | carnitine shuttle (GO:0006853) | 3.87738141 |
36 | protein complex biogenesis (GO:0070271) | 3.86102072 |
37 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.85079492 |
38 | 2-oxoglutarate metabolic process (GO:0006103) | 3.84172812 |
39 | purine nucleotide salvage (GO:0032261) | 3.82430249 |
40 | cardiac myofibril assembly (GO:0055003) | 3.78888515 |
41 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.78731875 |
42 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.78731875 |
43 | chaperone-mediated protein transport (GO:0072321) | 3.78107647 |
44 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.77405345 |
45 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.76546990 |
46 | negative regulation of ligase activity (GO:0051352) | 3.76546990 |
47 | inner mitochondrial membrane organization (GO:0007007) | 3.74887912 |
48 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.74728137 |
49 | branched-chain amino acid catabolic process (GO:0009083) | 3.74082298 |
50 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.72932805 |
51 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.72932805 |
52 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.72932805 |
53 | ATP biosynthetic process (GO:0006754) | 3.71952670 |
54 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.68007433 |
55 | heart contraction (GO:0060047) | 3.66061470 |
56 | heart process (GO:0003015) | 3.66061470 |
57 | cardiac muscle contraction (GO:0060048) | 3.63559012 |
58 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.62231646 |
59 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.60668035 |
60 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.60668035 |
61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.55552163 |
62 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.53500259 |
63 | regulation of relaxation of muscle (GO:1901077) | 3.51629571 |
64 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.47753642 |
65 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.46071903 |
66 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.46071903 |
67 | branched-chain amino acid metabolic process (GO:0009081) | 3.45926530 |
68 | valine metabolic process (GO:0006573) | 3.43092735 |
69 | regulation of mitochondrial translation (GO:0070129) | 3.40470745 |
70 | * tricarboxylic acid metabolic process (GO:0072350) | 3.40017940 |
71 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.35967328 |
72 | myofibril assembly (GO:0030239) | 3.35863339 |
73 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.35811575 |
74 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.35746199 |
75 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.35746199 |
76 | response to interferon-beta (GO:0035456) | 3.32631389 |
77 | pentose metabolic process (GO:0019321) | 3.31874416 |
78 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.31502920 |
79 | cellular respiration (GO:0045333) | 3.30942415 |
80 | regulation of oxidative phosphorylation (GO:0002082) | 3.30362638 |
81 | nucleotide salvage (GO:0043173) | 3.29470177 |
82 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.29402523 |
83 | fatty acid beta-oxidation (GO:0006635) | 3.28587304 |
84 | protein deneddylation (GO:0000338) | 3.27729206 |
85 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.27319548 |
86 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.26935637 |
87 | metallo-sulfur cluster assembly (GO:0031163) | 3.24706564 |
88 | iron-sulfur cluster assembly (GO:0016226) | 3.24706564 |
89 | regulation of skeletal muscle contraction (GO:0014819) | 3.23907056 |
90 | Golgi transport vesicle coating (GO:0048200) | 3.23170702 |
91 | COPI coating of Golgi vesicle (GO:0048205) | 3.23170702 |
92 | lysine catabolic process (GO:0006554) | 3.22373239 |
93 | lysine metabolic process (GO:0006553) | 3.22373239 |
94 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.21654877 |
95 | positive regulation of ligase activity (GO:0051351) | 3.20925179 |
96 | protein targeting to mitochondrion (GO:0006626) | 3.18792655 |
97 | regulation of cellular respiration (GO:0043457) | 3.17767252 |
98 | regulation of cellular amine metabolic process (GO:0033238) | 3.17711355 |
99 | formation of translation preinitiation complex (GO:0001731) | 3.17256378 |
100 | fatty acid transmembrane transport (GO:1902001) | 3.17015064 |
101 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.15433293 |
102 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.11551267 |
103 | respiratory chain complex IV assembly (GO:0008535) | 3.10175154 |
104 | proteasome assembly (GO:0043248) | 3.08606137 |
105 | regulation of actin filament-based movement (GO:1903115) | 3.06369721 |
106 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.05701590 |
107 | daunorubicin metabolic process (GO:0044597) | 3.04956636 |
108 | polyketide metabolic process (GO:0030638) | 3.04956636 |
109 | doxorubicin metabolic process (GO:0044598) | 3.04956636 |
110 | nucleoside salvage (GO:0043174) | 3.02426696 |
111 | positive regulation of cell cycle arrest (GO:0071158) | 3.02012284 |
112 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.98043366 |
113 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.96733118 |
114 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.96733118 |
115 | establishment of protein localization to mitochondrion (GO:0072655) | 2.96134771 |
116 | mitochondrial transport (GO:0006839) | 2.94807537 |
117 | viral transcription (GO:0019083) | 2.93554995 |
118 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.92675493 |
119 | GTP biosynthetic process (GO:0006183) | 2.92200987 |
120 | pyrimidine-containing compound salvage (GO:0008655) | 2.92009074 |
121 | pyrimidine nucleoside salvage (GO:0043097) | 2.92009074 |
122 | carnitine transmembrane transport (GO:1902603) | 2.91744746 |
123 | mitochondrial calcium ion transport (GO:0006851) | 2.91331883 |
124 | cardiac muscle cell development (GO:0055013) | 2.91060481 |
125 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.90464491 |
126 | cytochrome complex assembly (GO:0017004) | 2.90121649 |
127 | actin-mediated cell contraction (GO:0070252) | 2.89516318 |
128 | translational elongation (GO:0006414) | 2.88697395 |
129 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.88670777 |
130 | biotin metabolic process (GO:0006768) | 2.87839879 |
131 | striated muscle contraction (GO:0006941) | 2.87615115 |
132 | pentose-phosphate shunt (GO:0006098) | 2.86343662 |
133 | NIK/NF-kappaB signaling (GO:0038061) | 2.85836477 |
134 | gluconeogenesis (GO:0006094) | 2.85754613 |
135 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.85354991 |
136 | translational termination (GO:0006415) | 2.84126887 |
137 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.83856254 |
138 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.82523025 |
139 | galactose catabolic process (GO:0019388) | 2.81928023 |
140 | aspartate family amino acid catabolic process (GO:0009068) | 2.81885568 |
141 | amino-acid betaine transport (GO:0015838) | 2.80093711 |
142 | carnitine transport (GO:0015879) | 2.80093711 |
143 | nucleoside monophosphate biosynthetic process (GO:0009124) | 2.79646862 |
144 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.79634167 |
145 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.78884763 |
146 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.78726130 |
147 | negative regulation of protein ubiquitination (GO:0031397) | 2.78123940 |
148 | protein localization to mitochondrion (GO:0070585) | 2.77588724 |
149 | mitotic nuclear envelope reassembly (GO:0007084) | 2.74883783 |
150 | nuclear envelope reassembly (GO:0031468) | 2.74883783 |
151 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.74838674 |
152 | regulation of ligase activity (GO:0051340) | 2.74750087 |
153 | hexose biosynthetic process (GO:0019319) | 2.74498217 |
154 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.74169189 |
155 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.73843471 |
156 | hydrogen ion transmembrane transport (GO:1902600) | 2.73272332 |
157 | cellular response to interferon-beta (GO:0035458) | 2.73257676 |
158 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.72920725 |
159 | cullin deneddylation (GO:0010388) | 2.72817052 |
160 | regulation of sequestering of triglyceride (GO:0010889) | 2.72630471 |
161 | establishment of viral latency (GO:0019043) | 2.69358353 |
162 | regulation of cell cycle arrest (GO:0071156) | 2.67728994 |
163 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.66203014 |
164 | viral protein processing (GO:0019082) | 2.65941099 |
165 | GMP metabolic process (GO:0046037) | 2.65639344 |
166 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.65311478 |
167 | virion assembly (GO:0019068) | 2.64338031 |
168 | monosaccharide biosynthetic process (GO:0046364) | 2.62544335 |
169 | galactose metabolic process (GO:0006012) | 2.62104304 |
170 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.61299558 |
171 | NADPH regeneration (GO:0006740) | 2.61093478 |
172 | UTP biosynthetic process (GO:0006228) | 2.60388973 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.75190038 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.20295056 |
3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.02323945 |
4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.79615178 |
5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.73221358 |
6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.69024547 |
7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.36688252 |
8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.26823927 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.26399340 |
10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.22848652 |
11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.17393017 |
12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.16070535 |
13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.96459570 |
14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.82719414 |
15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.76374479 |
16 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.75566065 |
17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.48617026 |
18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.47202728 |
19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.42960314 |
20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.41288948 |
21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32174930 |
22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.30611668 |
23 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.29670899 |
24 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.26953399 |
25 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.26711367 |
26 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.26304256 |
27 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.22999439 |
28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.18472341 |
29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.05330287 |
30 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03449496 |
31 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.02972795 |
32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99890271 |
33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.99704720 |
34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98630786 |
35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.98384646 |
36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97485380 |
37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.96179250 |
38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93848337 |
39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.91385484 |
40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.88262962 |
41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87204251 |
42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.82455004 |
43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75712604 |
44 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75464372 |
45 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.74099079 |
46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72793780 |
47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68435365 |
48 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.66290884 |
49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.64620830 |
50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64410515 |
51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.63883179 |
52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63343877 |
53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60478536 |
54 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.54833160 |
55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53604941 |
56 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.52753719 |
57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.47634672 |
58 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45670602 |
59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44321784 |
60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43699525 |
61 | P68_20966046_ChIP-Seq_HELA_Human | 1.43325685 |
62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42831803 |
63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42516203 |
64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40493210 |
65 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36350840 |
66 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.35559613 |
67 | MYC_22102868_ChIP-Seq_BL_Human | 1.34793092 |
68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32832345 |
69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31240066 |
70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30655479 |
71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28078590 |
72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27869791 |
73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.27809825 |
74 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.27555947 |
75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27389774 |
76 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.25651804 |
77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25219641 |
78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25091016 |
79 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.22549322 |
80 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.22539249 |
81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21598083 |
82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19529649 |
83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.18572455 |
84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18125855 |
85 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.17730930 |
86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17698542 |
87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17634662 |
88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15082298 |
89 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14677524 |
90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14189045 |
91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13846119 |
92 | MAF_26560356_Chip-Seq_TH2_Human | 1.13427395 |
93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13104456 |
94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12805885 |
95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12781850 |
96 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.10908048 |
97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09082174 |
98 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.08698352 |
99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08123629 |
100 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07948991 |
101 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07768705 |
102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07436042 |
103 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06546571 |
104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06309055 |
105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05628022 |
106 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05551960 |
107 | MAF_26560356_Chip-Seq_TH1_Human | 1.04053739 |
108 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03242423 |
109 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02889126 |
110 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02644172 |
111 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.01900693 |
112 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01819009 |
113 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01249171 |
114 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.01193191 |
115 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01016259 |
116 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.97256971 |
117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96209660 |
118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95859621 |
119 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.95516086 |
120 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.95396465 |
121 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.95326139 |
122 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93688309 |
123 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.93584521 |
124 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93395374 |
125 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91977442 |
126 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.89211280 |
127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88527634 |
128 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86167081 |
129 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85671058 |
130 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.85637128 |
131 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82830397 |
132 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82235319 |
133 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81353818 |
134 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.81050765 |
135 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.79860976 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 5.69059287 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 5.59233614 |
3 | MP0004084_abnormal_cardiac_muscle | 4.62661844 |
4 | MP0005058_abnormal_lysosome_morphology | 4.26012544 |
5 | MP0004215_abnormal_myocardial_fiber | 4.18637263 |
6 | MP0000751_myopathy | 4.17983425 |
7 | MP0006036_abnormal_mitochondrial_physio | 3.62466205 |
8 | MP0004036_abnormal_muscle_relaxation | 3.57167875 |
9 | MP0000749_muscle_degeneration | 3.50833770 |
10 | MP0008260_abnormal_autophagy | 3.45404825 |
11 | MP0005330_cardiomyopathy | 3.11571102 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.88690311 |
13 | MP0004130_abnormal_muscle_cell | 2.66718032 |
14 | MP0009840_abnormal_foam_cell | 2.45803620 |
15 | MP0000750_abnormal_muscle_regeneration | 2.33953738 |
16 | MP0002132_abnormal_respiratory_system | 2.33313203 |
17 | MP0005670_abnormal_white_adipose | 2.31172037 |
18 | MP0006035_abnormal_mitochondrial_morpho | 2.29889500 |
19 | MP0008775_abnormal_heart_ventricle | 2.28430889 |
20 | MP0004087_abnormal_muscle_fiber | 2.26742877 |
21 | MP0002269_muscular_atrophy | 2.23830077 |
22 | MP0004147_increased_porphyrin_level | 2.23060022 |
23 | MP0005671_abnormal_response_to | 2.21856772 |
24 | MP0002972_abnormal_cardiac_muscle | 2.18160547 |
25 | MP0009333_abnormal_splenocyte_physiolog | 2.15667074 |
26 | MP0004145_abnormal_muscle_electrophysio | 2.15593238 |
27 | MP0002106_abnormal_muscle_physiology | 2.10706688 |
28 | MP0003221_abnormal_cardiomyocyte_apopto | 2.09437970 |
29 | MP0002148_abnormal_hypersensitivity_rea | 2.08769290 |
30 | MP0003137_abnormal_impulse_conducting | 2.08678159 |
31 | MP0004233_abnormal_muscle_weight | 2.08245031 |
32 | MP0005620_abnormal_muscle_contractility | 2.04332417 |
33 | MP0001544_abnormal_cardiovascular_syste | 2.03028950 |
34 | MP0005385_cardiovascular_system_phenoty | 2.03028950 |
35 | MP0009785_altered_susceptibility_to | 2.01227405 |
36 | MP0003786_premature_aging | 1.95761774 |
37 | MP0005451_abnormal_body_composition | 1.94116989 |
38 | MP0001835_abnormal_antigen_presentation | 1.92679043 |
39 | MP0003436_decreased_susceptibility_to | 1.91565471 |
40 | MP0000747_muscle_weakness | 1.86756616 |
41 | MP0001905_abnormal_dopamine_level | 1.81200107 |
42 | MP0002736_abnormal_nociception_after | 1.78647677 |
43 | MP0003075_altered_response_to | 1.77644031 |
44 | MP0010630_abnormal_cardiac_muscle | 1.75846260 |
45 | MP0005025_abnormal_response_to | 1.73437970 |
46 | MP0004484_altered_response_of | 1.73346154 |
47 | MP0002396_abnormal_hematopoietic_system | 1.69243792 |
48 | MP0006138_congestive_heart_failure | 1.67008166 |
49 | MP0000759_abnormal_skeletal_muscle | 1.63863321 |
50 | MP0005464_abnormal_platelet_physiology | 1.63537492 |
51 | MP0005666_abnormal_adipose_tissue | 1.63062213 |
52 | MP0005369_muscle_phenotype | 1.61435966 |
53 | MP0009278_abnormal_bone_marrow | 1.61358098 |
54 | MP0004510_myositis | 1.60541780 |
55 | MP0005000_abnormal_immune_tolerance | 1.58003627 |
56 | MP0006082_CNS_inflammation | 1.56990276 |
57 | MP0004043_abnormal_pH_regulation | 1.53080506 |
58 | MP0002332_abnormal_exercise_endurance | 1.51276981 |
59 | MP0003172_abnormal_lysosome_physiology | 1.46718315 |
60 | MP0003828_pulmonary_edema | 1.46652683 |
61 | MP0002419_abnormal_innate_immunity | 1.46157002 |
62 | MP0003693_abnormal_embryo_hatching | 1.43619556 |
63 | MP0002277_abnormal_respiratory_mucosa | 1.43408031 |
64 | MP0004085_abnormal_heartbeat | 1.41996187 |
65 | MP0002723_abnormal_immune_serum | 1.41977535 |
66 | MP0000372_irregular_coat_pigmentation | 1.39955485 |
67 | MP0005266_abnormal_metabolism | 1.36516008 |
68 | MP0003806_abnormal_nucleotide_metabolis | 1.27615774 |
69 | MP0004957_abnormal_blastocyst_morpholog | 1.25746807 |
70 | MP0002420_abnormal_adaptive_immunity | 1.24608065 |
71 | MP0001790_abnormal_immune_system | 1.24298568 |
72 | MP0005387_immune_system_phenotype | 1.24298568 |
73 | MP0003186_abnormal_redox_activity | 1.23440929 |
74 | MP0000685_abnormal_immune_system | 1.22612932 |
75 | MP0001819_abnormal_immune_cell | 1.22109446 |
76 | MP0001968_abnormal_touch/_nociception | 1.20772107 |
77 | MP0008469_abnormal_protein_level | 1.20089693 |
78 | MP0002127_abnormal_cardiovascular_syste | 1.19419429 |
79 | MP0002452_abnormal_antigen_presenting | 1.19120297 |
80 | MP0001845_abnormal_inflammatory_respons | 1.19064971 |
81 | MP0010030_abnormal_orbit_morphology | 1.17354248 |
82 | MP0001727_abnormal_embryo_implantation | 1.17346414 |
83 | MP0002909_abnormal_adrenal_gland | 1.16768246 |
84 | MP0003303_peritoneal_inflammation | 1.15290908 |
85 | MP0000858_altered_metastatic_potential | 1.13719306 |
86 | MP0000013_abnormal_adipose_tissue | 1.13446435 |
87 | MP0010094_abnormal_chromosome_stability | 1.12383196 |
88 | MP0001542_abnormal_bone_strength | 1.12132254 |
89 | MP0003656_abnormal_erythrocyte_physiolo | 1.12109807 |
90 | MP0005166_decreased_susceptibility_to | 1.08224801 |
91 | MP0008875_abnormal_xenobiotic_pharmacok | 1.08039137 |
92 | MP0000358_abnormal_cell_content/ | 1.07409955 |
93 | MP0002822_catalepsy | 1.05456091 |
94 | MP0005375_adipose_tissue_phenotype | 1.04255079 |
95 | MP0000343_altered_response_to | 1.04056702 |
96 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03358512 |
97 | MP0005319_abnormal_enzyme/_coenzyme | 1.02322191 |
98 | MP0001800_abnormal_humoral_immune | 0.97904555 |
99 | MP0001853_heart_inflammation | 0.97632301 |
100 | MP0008874_decreased_physiological_sensi | 0.97504335 |
101 | MP0002653_abnormal_ependyma_morphology | 0.97129529 |
102 | MP0002638_abnormal_pupillary_reflex | 0.96034765 |
103 | MP0002429_abnormal_blood_cell | 0.95618819 |
104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94896694 |
105 | MP0002971_abnormal_brown_adipose | 0.93808878 |
106 | MP0000716_abnormal_immune_system | 0.93577896 |
107 | MP0009764_decreased_sensitivity_to | 0.93183173 |
108 | MP0005535_abnormal_body_temperature | 0.93069050 |
109 | MP0005084_abnormal_gallbladder_morpholo | 0.91485171 |
110 | MP0000230_abnormal_systemic_arterial | 0.91004616 |
111 | MP0005332_abnormal_amino_acid | 0.88985388 |
112 | MP0003111_abnormal_nucleus_morphology | 0.87923061 |
113 | MP0003077_abnormal_cell_cycle | 0.87318693 |
114 | MP0002078_abnormal_glucose_homeostasis | 0.86917646 |
115 | MP0003763_abnormal_thymus_physiology | 0.86361730 |
116 | MP0001533_abnormal_skeleton_physiology | 0.84970844 |
117 | MP0008058_abnormal_DNA_repair | 0.83193630 |
118 | MP0003724_increased_susceptibility_to | 0.80989728 |
119 | MP0001764_abnormal_homeostasis | 0.80342012 |
120 | MP0000703_abnormal_thymus_morphology | 0.79804385 |
121 | MP0001873_stomach_inflammation | 0.79381606 |
122 | MP0005165_increased_susceptibility_to | 0.79039956 |
123 | MP0004808_abnormal_hematopoietic_stem | 0.77778081 |
124 | MP0005410_abnormal_fertilization | 0.76013572 |
125 | MP0002970_abnormal_white_adipose | 0.75076595 |
126 | MP0008873_increased_physiological_sensi | 0.74304052 |
127 | MP0003045_fibrosis | 0.73975556 |
128 | MP0008789_abnormal_olfactory_epithelium | 0.73055391 |
129 | MP0000003_abnormal_adipose_tissue | 0.72708453 |
130 | MP0005075_abnormal_melanosome_morpholog | 0.72676993 |
131 | MP0000015_abnormal_ear_pigmentation | 0.72337024 |
132 | MP0002163_abnormal_gland_morphology | 0.72282370 |
133 | MP0000266_abnormal_heart_morphology | 0.72205354 |
134 | MP0002405_respiratory_system_inflammati | 0.70740133 |
135 | MP0005397_hematopoietic_system_phenotyp | 0.69350614 |
136 | MP0001545_abnormal_hematopoietic_system | 0.69350614 |
137 | MP0009763_increased_sensitivity_to | 0.68062634 |
138 | MP0010155_abnormal_intestine_physiology | 0.67551940 |
139 | MP0009643_abnormal_urine_homeostasis | 0.66840770 |
140 | MP0003879_abnormal_hair_cell | 0.66631612 |
141 | MP0005636_abnormal_mineral_homeostasis | 0.66100281 |
142 | MP0001529_abnormal_vocalization | 0.65557003 |
143 | MP0009697_abnormal_copulation | 0.64923751 |
144 | MP0001765_abnormal_ion_homeostasis | 0.61851825 |
145 | MP0005452_abnormal_adipose_tissue | 0.59692157 |
146 | MP0005376_homeostasis/metabolism_phenot | 0.58538198 |
147 | MP0008007_abnormal_cellular_replicative | 0.58249627 |
148 | MP0004142_abnormal_muscle_tone | 0.55753239 |
149 | MP0008872_abnormal_physiological_respon | 0.54024602 |
150 | MP0004185_abnormal_adipocyte_glucose | 0.51852692 |
151 | MP0002234_abnormal_pharynx_morphology | 0.51423081 |
152 | MP0005334_abnormal_fat_pad | 0.51194978 |
153 | MP0003123_paternal_imprinting | 0.50739344 |
154 | MP0009115_abnormal_fat_cell | 0.50710690 |
155 | MP0000313_abnormal_cell_death | 0.49962924 |
156 | MP0000490_abnormal_crypts_of | 0.49755075 |
157 | MP0003984_embryonic_growth_retardation | 0.46640617 |
158 | MP0003953_abnormal_hormone_level | 0.46595697 |
159 | MP0002722_abnormal_immune_system | 0.45576875 |
160 | MP0008569_lethality_at_weaning | 0.44250020 |
161 | MP0000689_abnormal_spleen_morphology | 0.43859502 |
162 | MP0002080_prenatal_lethality | 0.43458548 |
163 | MP0001756_abnormal_urination | 0.42836910 |
164 | MP0002398_abnormal_bone_marrow | 0.42367938 |
165 | MP0003866_abnormal_defecation | 0.42210730 |
166 | MP0002088_abnormal_embryonic_growth/wei | 0.42105178 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hepatic necrosis (HP:0002605) | 5.36307013 |
2 | Hepatocellular necrosis (HP:0001404) | 5.10665853 |
3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.04483370 |
4 | Acute necrotizing encephalopathy (HP:0006965) | 4.88748298 |
5 | Myoglobinuria (HP:0002913) | 4.72163621 |
6 | Mitochondrial inheritance (HP:0001427) | 4.56286979 |
7 | Exercise-induced myalgia (HP:0003738) | 4.43676756 |
8 | Increased CSF lactate (HP:0002490) | 4.38483460 |
9 | Acute encephalopathy (HP:0006846) | 4.35701714 |
10 | Sudden death (HP:0001699) | 4.26998676 |
11 | Hyperalaninemia (HP:0003348) | 4.23333403 |
12 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.23333403 |
13 | Abnormality of alanine metabolism (HP:0010916) | 4.23333403 |
14 | Rhabdomyolysis (HP:0003201) | 4.09261153 |
15 | Increased muscle lipid content (HP:0009058) | 4.07472814 |
16 | Exercise-induced muscle cramps (HP:0003710) | 4.07324037 |
17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.93751169 |
18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.93751169 |
19 | Progressive macrocephaly (HP:0004481) | 3.92690837 |
20 | Lactic acidosis (HP:0003128) | 3.89000242 |
21 | Ventricular tachycardia (HP:0004756) | 3.84758133 |
22 | Palpitations (HP:0001962) | 3.83923919 |
23 | Abnormal gallbladder physiology (HP:0012438) | 3.75722014 |
24 | Cholecystitis (HP:0001082) | 3.75722014 |
25 | Calf muscle hypertrophy (HP:0008981) | 3.70159104 |
26 | Increased intramyocellular lipid droplets (HP:0012240) | 3.68510656 |
27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.62846327 |
28 | Dicarboxylic aciduria (HP:0003215) | 3.53237614 |
29 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.53237614 |
30 | Petechiae (HP:0000967) | 3.45615116 |
31 | Exercise intolerance (HP:0003546) | 3.45452320 |
32 | Increased serum lactate (HP:0002151) | 3.43451492 |
33 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.41050922 |
34 | Generalized aminoaciduria (HP:0002909) | 3.36589196 |
35 | Ragged-red muscle fibers (HP:0003200) | 3.34576550 |
36 | Cerebral edema (HP:0002181) | 3.33101308 |
37 | Lipoatrophy (HP:0100578) | 3.27763862 |
38 | Respiratory failure (HP:0002878) | 3.25154612 |
39 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.20430107 |
40 | Subaortic stenosis (HP:0001682) | 3.20430107 |
41 | Hypokinesia (HP:0002375) | 3.19297106 |
42 | Increased serum pyruvate (HP:0003542) | 3.16641526 |
43 | Abnormality of glycolysis (HP:0004366) | 3.16641526 |
44 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15954219 |
45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15954219 |
46 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15954219 |
47 | Atrial fibrillation (HP:0005110) | 3.14981920 |
48 | Supraventricular tachycardia (HP:0004755) | 3.09289597 |
49 | Renal Fanconi syndrome (HP:0001994) | 3.09161553 |
50 | Prolonged neonatal jaundice (HP:0006579) | 3.06427764 |
51 | Lipid accumulation in hepatocytes (HP:0006561) | 3.03225524 |
52 | Supraventricular arrhythmia (HP:0005115) | 2.98773715 |
53 | Primary atrial arrhythmia (HP:0001692) | 2.97082387 |
54 | Muscle fiber splitting (HP:0003555) | 2.95015033 |
55 | Ketoacidosis (HP:0001993) | 2.89151395 |
56 | Dilated cardiomyopathy (HP:0001644) | 2.86222532 |
57 | Type I transferrin isoform profile (HP:0003642) | 2.84883507 |
58 | Abnormality of the calf musculature (HP:0001430) | 2.84099786 |
59 | Hyperglycinuria (HP:0003108) | 2.82822434 |
60 | Hypoglycemic coma (HP:0001325) | 2.81983928 |
61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81662438 |
62 | Bundle branch block (HP:0011710) | 2.72092144 |
63 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.69631861 |
64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63912505 |
65 | Hepatosplenomegaly (HP:0001433) | 2.63673375 |
66 | Myotonia (HP:0002486) | 2.61831193 |
67 | Esophageal neoplasm (HP:0100751) | 2.61187891 |
68 | Neoplasm of head and neck (HP:0012288) | 2.61187891 |
69 | Asymmetric septal hypertrophy (HP:0001670) | 2.56568476 |
70 | Neuroendocrine neoplasm (HP:0100634) | 2.55333938 |
71 | Distal lower limb muscle weakness (HP:0009053) | 2.54504415 |
72 | Rough bone trabeculation (HP:0100670) | 2.51034922 |
73 | Vertebral compression fractures (HP:0002953) | 2.49517960 |
74 | Progressive neurologic deterioration (HP:0002344) | 2.46856115 |
75 | Myopathic facies (HP:0002058) | 2.46721566 |
76 | Pheochromocytoma (HP:0002666) | 2.46713365 |
77 | CNS demyelination (HP:0007305) | 2.46708050 |
78 | Microretrognathia (HP:0000308) | 2.46349667 |
79 | Neoplasm of the adrenal gland (HP:0100631) | 2.43604925 |
80 | Emotional lability (HP:0000712) | 2.41854988 |
81 | Syncope (HP:0001279) | 2.41803045 |
82 | Loss of speech (HP:0002371) | 2.41535333 |
83 | Lethargy (HP:0001254) | 2.41086079 |
84 | Progressive muscle weakness (HP:0003323) | 2.38496650 |
85 | Abnormality of macrophages (HP:0004311) | 2.36817877 |
86 | Progressive microcephaly (HP:0000253) | 2.35938674 |
87 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.35826264 |
88 | Abnormal number of erythroid precursors (HP:0012131) | 2.32006812 |
89 | Opisthotonus (HP:0002179) | 2.31634611 |
90 | Conjunctival hamartoma (HP:0100780) | 2.31613958 |
91 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.30488155 |
92 | EMG: myopathic abnormalities (HP:0003458) | 2.30456594 |
93 | Heart block (HP:0012722) | 2.30443845 |
94 | 3-Methylglutaconic aciduria (HP:0003535) | 2.29448717 |
95 | Atrioventricular block (HP:0001678) | 2.28985151 |
96 | Nausea (HP:0002018) | 2.26970051 |
97 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.26927229 |
98 | Hypertensive crisis (HP:0100735) | 2.25097936 |
99 | Methylmalonic aciduria (HP:0012120) | 2.24017157 |
100 | Multiple enchondromatosis (HP:0005701) | 2.23642429 |
101 | Ketosis (HP:0001946) | 2.22615790 |
102 | Tinnitus (HP:0000360) | 2.22127534 |
103 | Aplastic anemia (HP:0001915) | 2.22122215 |
104 | Cerebral hypomyelination (HP:0006808) | 2.21264538 |
105 | Prolonged QT interval (HP:0001657) | 2.20763496 |
106 | Hyperammonemia (HP:0001987) | 2.20492835 |
107 | Abnormality of glycine metabolism (HP:0010895) | 2.19304602 |
108 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.19304602 |
109 | Muscle stiffness (HP:0003552) | 2.19270212 |
110 | Optic disc pallor (HP:0000543) | 2.18962708 |
111 | Purpura (HP:0000979) | 2.17782828 |
112 | Respiratory difficulties (HP:0002880) | 2.17627504 |
113 | Cerebral palsy (HP:0100021) | 2.17476675 |
114 | Proximal tubulopathy (HP:0000114) | 2.17313540 |
115 | Ventricular arrhythmia (HP:0004308) | 2.16858375 |
116 | Axonal loss (HP:0003447) | 2.15915187 |
117 | Dysostosis multiplex (HP:0000943) | 2.13744390 |
118 | Testicular atrophy (HP:0000029) | 2.12303673 |
119 | Cholelithiasis (HP:0001081) | 2.09658089 |
120 | Ventricular fibrillation (HP:0001663) | 2.09467624 |
121 | J-shaped sella turcica (HP:0002680) | 2.09125752 |
122 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.08796404 |
123 | Exertional dyspnea (HP:0002875) | 2.07266264 |
124 | Unsteady gait (HP:0002317) | 2.07080394 |
125 | Microvesicular hepatic steatosis (HP:0001414) | 2.06957587 |
126 | Metabolic acidosis (HP:0001942) | 2.06263788 |
127 | Nuclear cataract (HP:0100018) | 2.06026617 |
128 | Abnormal atrioventricular conduction (HP:0005150) | 2.05115757 |
129 | Degeneration of anterior horn cells (HP:0002398) | 2.04625702 |
130 | Abnormality of the anterior horn cell (HP:0006802) | 2.04625702 |
131 | Systemic lupus erythematosus (HP:0002725) | 2.04345902 |
132 | Abnormal glycosylation (HP:0012345) | 2.02899669 |
133 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.02899669 |
134 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.02899669 |
135 | Abnormal protein glycosylation (HP:0012346) | 2.02899669 |
136 | Gliosis (HP:0002171) | 2.02112119 |
137 | Left ventricular hypertrophy (HP:0001712) | 2.01202080 |
138 | Increased connective tissue (HP:0009025) | 2.00629902 |
139 | Vomiting (HP:0002013) | 2.00173580 |
140 | Distal lower limb amyotrophy (HP:0008944) | 1.98332129 |
141 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.97713437 |
142 | Areflexia of lower limbs (HP:0002522) | 1.97303666 |
143 | Vacuolated lymphocytes (HP:0001922) | 1.92992837 |
144 | Limb-girdle muscle atrophy (HP:0003797) | 1.92498798 |
145 | Recurrent abscess formation (HP:0002722) | 1.91855584 |
146 | Increased serum ferritin (HP:0003281) | 1.89304977 |
147 | Reduced antithrombin III activity (HP:0001976) | 1.87097981 |
148 | Abnormality of lateral ventricle (HP:0030047) | 1.86849197 |
149 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86407560 |
150 | Obstructive lung disease (HP:0006536) | 1.86407560 |
151 | Gastrointestinal dysmotility (HP:0002579) | 1.86401833 |
152 | Mutism (HP:0002300) | 1.85787390 |
153 | Increased IgM level (HP:0003496) | 1.84402739 |
154 | Tongue fasciculations (HP:0001308) | 1.82971248 |
155 | Abnormal pupillary function (HP:0007686) | 1.82703156 |
156 | Abnormal trabecular bone morphology (HP:0100671) | 1.81651102 |
157 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81356468 |
158 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81356468 |
159 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81356468 |
160 | Upper limb muscle weakness (HP:0003484) | 1.78493878 |
161 | Abnormal gallbladder morphology (HP:0012437) | 1.75122589 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.91583576 |
2 | TESK1 | 4.35459991 |
3 | VRK2 | 3.96431420 |
4 | TESK2 | 3.85999250 |
5 | NEK1 | 3.81715532 |
6 | PDK4 | 3.49617238 |
7 | PDK3 | 3.49617238 |
8 | MYLK | 2.97455180 |
9 | OBSCN | 2.87469967 |
10 | TTN | 2.79885635 |
11 | FLT3 | 2.74629330 |
12 | LIMK1 | 2.66308428 |
13 | PHKG1 | 2.43297486 |
14 | PHKG2 | 2.43297486 |
15 | NME2 | 2.41194178 |
16 | WEE1 | 2.35227044 |
17 | STK16 | 2.34310997 |
18 | BUB1 | 2.27849993 |
19 | LMTK2 | 2.07760003 |
20 | PKN2 | 2.00794056 |
21 | EIF2AK1 | 1.98269365 |
22 | PINK1 | 1.96009281 |
23 | SIK3 | 1.95815574 |
24 | ERN1 | 1.93266459 |
25 | NME1 | 1.81689637 |
26 | PDK2 | 1.78223207 |
27 | MAP3K12 | 1.77834567 |
28 | MUSK | 1.75653270 |
29 | TSSK6 | 1.64603626 |
30 | MAP3K3 | 1.64103408 |
31 | BRSK2 | 1.57807789 |
32 | TRIB3 | 1.54047441 |
33 | CCNB1 | 1.51303328 |
34 | MAPKAPK3 | 1.49750560 |
35 | TIE1 | 1.45910133 |
36 | MAP2K3 | 1.42062561 |
37 | TBK1 | 1.41001748 |
38 | KIT | 1.37061161 |
39 | EPHA2 | 1.26244830 |
40 | TGFBR1 | 1.22884347 |
41 | RIPK4 | 1.22224886 |
42 | DAPK1 | 1.19135992 |
43 | KDR | 1.17855050 |
44 | ABL2 | 1.09645600 |
45 | SMG1 | 1.07618280 |
46 | IRAK4 | 1.06810656 |
47 | CSNK1G3 | 1.05260054 |
48 | SIK1 | 1.04711595 |
49 | GRK7 | 1.03441370 |
50 | CDK19 | 1.02643622 |
51 | VRK1 | 1.02488569 |
52 | EIF2AK3 | 1.02371853 |
53 | MAP4K2 | 1.02328682 |
54 | RPS6KB2 | 1.02326110 |
55 | PIK3CA | 0.99641002 |
56 | ILK | 0.99584933 |
57 | BRSK1 | 0.97468123 |
58 | ACVR1B | 0.95400617 |
59 | CAMK1 | 0.93745780 |
60 | MAP3K11 | 0.93722518 |
61 | ZAK | 0.89022599 |
62 | MST4 | 0.87784211 |
63 | TNK2 | 0.87614721 |
64 | MAP4K1 | 0.86064907 |
65 | PIM2 | 0.83987314 |
66 | PAK1 | 0.83934807 |
67 | CAMK2G | 0.83832166 |
68 | TAOK2 | 0.83053617 |
69 | STK24 | 0.82462256 |
70 | CAMKK2 | 0.82330615 |
71 | TRIM28 | 0.82282249 |
72 | PIK3CG | 0.80384769 |
73 | MAP2K6 | 0.78250960 |
74 | TYK2 | 0.78149609 |
75 | SRPK1 | 0.77153326 |
76 | IKBKB | 0.77142005 |
77 | PRKD3 | 0.74659410 |
78 | DYRK3 | 0.74105704 |
79 | TAOK1 | 0.72173337 |
80 | SCYL2 | 0.70211407 |
81 | BTK | 0.69582100 |
82 | PRKCI | 0.68331686 |
83 | MST1R | 0.67036821 |
84 | MAPK12 | 0.66197969 |
85 | CSNK1A1L | 0.65649494 |
86 | TEC | 0.63996793 |
87 | PBK | 0.63714350 |
88 | IKBKE | 0.62649075 |
89 | BRAF | 0.61239000 |
90 | PRPF4B | 0.61087471 |
91 | EPHB1 | 0.58945946 |
92 | PAK6 | 0.58839352 |
93 | MINK1 | 0.58500641 |
94 | CSNK1G2 | 0.57958446 |
95 | LRRK2 | 0.56397721 |
96 | AURKB | 0.56238255 |
97 | TXK | 0.55711544 |
98 | CAMK2D | 0.54740597 |
99 | RPS6KC1 | 0.53905870 |
100 | RPS6KL1 | 0.53905870 |
101 | GRK5 | 0.53291017 |
102 | CDK8 | 0.52726522 |
103 | SIK2 | 0.52613449 |
104 | DAPK3 | 0.50372556 |
105 | CSF1R | 0.50197921 |
106 | SYK | 0.49505392 |
107 | FES | 0.48293873 |
108 | STK4 | 0.48141927 |
109 | ZAP70 | 0.47422495 |
110 | CDC7 | 0.46790475 |
111 | CDK14 | 0.46371502 |
112 | PLK1 | 0.45514932 |
113 | IRAK3 | 0.45493957 |
114 | RPS6KA6 | 0.45277280 |
115 | TLK1 | 0.45155730 |
116 | AKT2 | 0.45051470 |
117 | PRKAA1 | 0.44396837 |
118 | IRAK2 | 0.44177229 |
119 | MAPK11 | 0.43807651 |
120 | MAP3K5 | 0.42919844 |
121 | MAPKAPK2 | 0.42186368 |
122 | ATR | 0.41331287 |
123 | CAMK4 | 0.39514969 |
124 | CSNK1G1 | 0.39141967 |
125 | CDK11A | 0.38804780 |
126 | CDK4 | 0.38665027 |
127 | CDK18 | 0.38457347 |
128 | MAP3K8 | 0.36430938 |
129 | DAPK2 | 0.36336143 |
130 | TGFBR2 | 0.35828631 |
131 | CDK15 | 0.35300799 |
132 | MAP2K7 | 0.35049798 |
133 | PASK | 0.34473634 |
134 | CSNK2A1 | 0.33944374 |
135 | PDPK1 | 0.33428747 |
136 | MAP3K7 | 0.33258630 |
137 | BLK | 0.32823567 |
138 | WNK3 | 0.32509372 |
139 | CSNK2A2 | 0.32239769 |
140 | PRKG2 | 0.31735479 |
141 | PRKACA | 0.31271472 |
142 | CAMK2B | 0.31164034 |
143 | TNIK | 0.31155649 |
144 | EEF2K | 0.30140520 |
145 | PRKACB | 0.29932399 |
146 | MAPK4 | 0.29823278 |
147 | PRKD1 | 0.29717686 |
148 | ARAF | 0.29522149 |
149 | AURKA | 0.28425579 |
150 | NEK2 | 0.27840336 |
151 | CAMKK1 | 0.27546033 |
152 | PAK4 | 0.26873704 |
153 | PRKAA2 | 0.25769625 |
154 | MAP2K4 | 0.25294857 |
155 | GRK6 | 0.23470328 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.39554946 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.89747208 |
3 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.84579546 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.75740700 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.05859590 |
6 | Proteasome_Homo sapiens_hsa03050 | 2.75478643 |
7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.75105921 |
8 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.69125039 |
9 | Ribosome_Homo sapiens_hsa03010 | 2.59447274 |
10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.54772089 |
11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.49184484 |
12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.35935547 |
13 | DNA replication_Homo sapiens_hsa03030 | 2.34027571 |
14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.28109775 |
15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25996056 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08429380 |
17 | Mismatch repair_Homo sapiens_hsa03430 | 1.93698454 |
18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87934305 |
19 | RNA polymerase_Homo sapiens_hsa03020 | 1.71259326 |
20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.70872605 |
21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.69455809 |
22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67219961 |
23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.57054939 |
24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56893921 |
25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.53635769 |
26 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.50229183 |
27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40240847 |
28 | Lysosome_Homo sapiens_hsa04142 | 1.39987082 |
29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.39795823 |
30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38680099 |
31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32813768 |
32 | Base excision repair_Homo sapiens_hsa03410 | 1.32789615 |
33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26191946 |
34 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.19170735 |
35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17206305 |
36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17094336 |
37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13980489 |
38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13280372 |
39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.12543558 |
40 | Homologous recombination_Homo sapiens_hsa03440 | 1.07854271 |
41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.07580855 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07470958 |
43 | Spliceosome_Homo sapiens_hsa03040 | 1.06646955 |
44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04991169 |
45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00531804 |
46 | Purine metabolism_Homo sapiens_hsa00230 | 0.99793799 |
47 | Allograft rejection_Homo sapiens_hsa05330 | 0.93078254 |
48 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91312815 |
49 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88610494 |
50 | Shigellosis_Homo sapiens_hsa05131 | 0.87819255 |
51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86489351 |
52 | Asthma_Homo sapiens_hsa05310 | 0.85472924 |
53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85401016 |
54 | RNA transport_Homo sapiens_hsa03013 | 0.84716004 |
55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80378509 |
56 | RNA degradation_Homo sapiens_hsa03018 | 0.79917856 |
57 | Peroxisome_Homo sapiens_hsa04146 | 0.77210321 |
58 | Salmonella infection_Homo sapiens_hsa05132 | 0.75455365 |
59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.74538707 |
60 | Phagosome_Homo sapiens_hsa04145 | 0.72593979 |
61 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.72172773 |
62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70220026 |
63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68598527 |
64 | Protein export_Homo sapiens_hsa03060 | 0.66761509 |
65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62506695 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60027601 |
67 | Tuberculosis_Homo sapiens_hsa05152 | 0.59925777 |
68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59010193 |
69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58565557 |
70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57446397 |
71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56807400 |
72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56682040 |
73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56344526 |
74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52999908 |
75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52238641 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51902929 |
77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47188023 |
78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46083366 |
79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42995223 |
80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41404459 |
81 | Pertussis_Homo sapiens_hsa05133 | 0.41400083 |
82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40329469 |
83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39863665 |
84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39552689 |
85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39314615 |
86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39218611 |
87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38557279 |
88 | Endocytosis_Homo sapiens_hsa04144 | 0.38478815 |
89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36251104 |
90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35445640 |
91 | Cell cycle_Homo sapiens_hsa04110 | 0.34733552 |
92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34433169 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33988770 |
94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33189975 |
95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32342061 |
96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32101734 |
97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31892892 |
98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30432155 |
99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29325504 |
100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29263730 |
101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27860193 |
102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27074406 |
103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25183701 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.24903743 |
105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.24203813 |
106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.23325341 |
107 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.23306976 |
108 | Apoptosis_Homo sapiens_hsa04210 | 0.23156304 |
109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22912068 |
110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22380880 |
111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21969414 |
112 | Legionellosis_Homo sapiens_hsa05134 | 0.21872886 |
113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21743269 |
114 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.21703062 |
115 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.21647512 |
116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20668447 |
117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20098991 |
118 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.17367940 |
119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17085959 |
120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16500425 |
121 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.16084732 |
122 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.15971314 |
123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.15007417 |
124 | Basal transcription factors_Homo sapiens_hsa03022 | 0.14891825 |
125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.14828416 |
126 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14038973 |
127 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.13643462 |
128 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.13623996 |
129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13519753 |
130 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.12902243 |
131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.09584529 |
132 | Thyroid cancer_Homo sapiens_hsa05216 | 0.08695608 |
133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07691674 |
134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.06922238 |
135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.06893804 |
136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.06668166 |